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Major depressive disorder (MDD) affects up to 17% of the population, causing profound personal suffering and economic loss 1 . Clinical and preclinical studies have revealed that prolonged stress and MDD are associated with neuronal atrophy of cortical and limbic brain regions [2] [3] [4] [5] [6] [7] [8] [9] , but the molecular mechanisms underlying these morphological alterations have not yet been identified. Here, we show that stress increases levels of REDD1 (regulated in development and DNA damage responses-1), an inhibitor of mTORC1 (mammalian target of rapamycin complex-1; ref. 10) , in rat prefrontal cortex (PFC). This is concurrent with a decrease in phosphorylation of signaling targets of mTORC1, which is implicated in protein synthesis-dependent synaptic plasticity. We also found that REDD1 levels are increased in the postmortem PFC of human subjects with MDD relative to matched controls. Mutant mice with a deletion of the gene encoding REDD1 are resilient to the behavioral, synaptic and mTORC1 signaling deficits caused by chronic unpredictable stress, whereas viral-mediated overexpression of REDD1 in rat PFC is sufficient to cause anxiety-and depressive-like behaviors and neuronal atrophy. Taken together, these postmortem and preclinical findings identify REDD1 as a critical mediator of the atrophy of neurons and depressive behavior caused by chronic stress exposure.
Structural alterations of the nervous system have been implicated in depression, including postmortem findings demonstrating atrophy of PFC in human subjects with MDD [2] [3] [4] . Chronic stress decreases dendrite branching and spine density in rodents [5] [6] [7] [8] [9] , and these alterations are associated with depressive behavior, notably anhedonia 11, 12 . A recent study has reported decreased levels of mTORC1 signaling proteins in postmortem PFC of subjects with MDD 13 . Conversely, rapid-acting antidepressants increase mTORC1 signaling and synaptogenesis in rat PFC 14 . These findings suggest that stress could decrease synaptogenesis via inhibition of mTORC1.
To address this issue, we examined the influence of chronic unpredictable stress (CUS) on REDD1 (also known as DDIT4 or RTP801), which stabilizes the complex formed by tuberous sclerosis proteins 1 and 2 (TSC1-TSC2); this complex subsequently inhibits mTORC1dependent protein synthesis and cell growth 10 (Fig. 1a) . Exposure to CUS for 21 d, which decreases the number and function of spine synapses 11 , significantly increased REDD1 mRNA (P < 0.001) and protein (P < 0.05) expression in rat PFC (Fig. 1b) . One day of mild stress had no effect on REDD1 (Fig. 1c) , and levels of TSC2 protein were unaltered by CUS ( Supplementary Fig. 1a,b) . Consistent with our previous work 11 , we found that PSD-95, a postsynaptic protein involved in synapse and spine formation and function, is decreased by CUS in PFC (P < 0.05) ( Supplementary Fig. 1c ). REDD1 levels were not altered by CUS in the hippocampus, another region in which atrophy is observed following chronic stress ( Supplementary Fig. 1d ).
We also examined the effects of adrenal glucocorticoids, as their release is a key hypothalamic-pituitary-adrenal (HPA) axis endocrine response to stress. We found that REDD1 mRNA (P < 0.0001) and protein (P < 0.001) expression was significantly increased in PFC following administration of the synthetic glucocorticoid dexamethasone ( Supplementary Fig. 2a ), consistent with reports of increased REDD1 in response to glucocorticoid administration in muscle 15 and hippocampus 16 . Physiological induction of corticosterone by immobilization stress 17 (Supplementary Fig. 2e ) also significantly increased REDD1 (P < 0.05), and this effect was inhibited by glucocorticoid blockade with RU-486 (P < 0.05) ( Supplementary Fig. 2d ). These findings indicate that activation of the HPA axis underlies increased REDD1 expression in response to CUS. Consistent with previous work in the hippocampus 16 , we also found that REDD2 in PFC is decreased by glucocorticoid treatment (P < 0.05) ( Supplementary Fig. 2b) . REDD2 is also a negative regulator of mTORC1 (ref. 10) and may act with REDD1 to fine-tune mTORC1 signaling.
We also found that CUS (21 d), but not mild stress (1 d), decreases phosphorylation of the mTORC1 signaling targets p70 ribosomal S6 kinase (S6K) (P < 0.01) and eukaryotic translation initiation factor 4Ebinding protein-1 (4EBP1) (P < 0.05) in rat PFC ( Fig. 1d,e ). Further, we observed a significant decrease in phosphorylated serine-threonine kinase (p-Akt) (P < 0.05) and a trend toward decreased phosphorylation of extracellular signal-regulated kinase (p-ERK) (P < 0.06), kinases linked to activation of mTORC1 signaling. There was a nonsignificant trend toward decreased levels of p-mTOR (P = 0.26). Dexamethasone treatment similarly decreased mTORC1 signaling, as measured by p-S6K levels (P < 0.001) ( Supplementary Fig. 2c ).
To assess the relevance of REDD1 to MDD, we analyzed REDD1 expression in the postmortem dorsolateral PFC (dlPFC) of two separate cohorts of subjects with MDD. In the first cohort, there was a nonsignificant trend for an increase (1.22-fold) in REDD1 mRNA in the dlPFC of subjects with MDD relative to controls (P = 0.18). This effect was corroborated in the second cohort, where there was a significant 2.57-fold increase (P = 0.025). Combined analysis of the two cohorts revealed a significant overall 1.60-fold increase of REDD1 in patients with MDD relative to psychiatrically healthy controls (P = 0.012) ( Fig. 2a) . There was also a trend toward decreased levels of mTOR mRNA in the combined samples (P = 0.098) ( Fig. 2b) . Analysis of covariance (ANCOVA) revealed that neither sex nor medication status was a significant covariate for REDD1 or mTOR expression. Detailed demographic information is provided in Supplementary Tables 1 and 2. Sustained activation of the HPA axis, consistently observed in patients with MDD 18 , could underlie this observed increase of REDD1.
To directly test the role of REDD1 in the effects of chronic stress, we used mice with constitutive knockout of REDD1. We confirmed deletion of the gene encoding REDD1 in PFC (P < 0.0001) ( Supplementary Fig. 3a ). Knockout mice did not display any apparent physical or behavioral abnormalities, despite a previous report suggesting a role for REDD1 in embryonic development 19 ( Supplementary Fig. 3b-d ). This lack of baseline behavioral differences was not surprising, given the low level of REDD1 expression in brain 20 . However, CUS exposure (21 d), which causes anhedonic behavior (i.e., decreased sucrose consumption) in wild-type (WT) mice, had no effect in REDD1-knockout mice, indicating resilience to CUS ( Fig. 3a,b) . Two-way ANOVA revealed a significant effect of genotype (F(1,56) = 4.47; P < 0.05) and stress (F(1,56) = 5.809; P < 0.03), where the effect of CUS was dependent on genotype (F(1,56) = 4.157; P < 0.05). Sucrose consumption was significantly decreased in the WT CUS group relative to all other groups (P < 0.01). CUS also decreased p-S6K and p-4EBP levels in PFC of WT but not REDD1knockout mice ( Fig. 3c) . Two-way ANOVA for p-S6K revealed a There was a nonsignificant trend toward decreased levels of p-mTOR in the WT CUS group (P = 0.056) ( Fig. 3c) . CUS decreases serotonin (5-HT)-and hypocretin (Hcrt)-induced excitatory postsynaptic potentials (EPSCs) and the number of spine synapses in the distal tufts of layer V pyramidal neurons in the medial PFC (mPFC) 11 . Here, we tested whether REDD1-knockout mice are resilient to these CUS-induced cellular deficits. First, we found that EPSC responses to both 5-HT and Hcrt, which are stress-sensitive probes targeting the apical dendrite 21 , were significantly decreased in the WT CUS group compared to the unstressed groups (P < 0.05), and there was a trend toward a decrease relative to the knockout CUS group (P < 0.10) ( Fig. 3d) . Two-way ANOVA for 5-HT-induced EPSCs in layer V pyramidal neurons of the mPFC showed a significant main effect of stress (F(1,60) = 6.131, P < 0.05) and a trend for a main effect of genotype (F(1,60) = 3.124, P < 0.10), but the effect of CUS did not depend on the genotype. Two-way ANOVA of Hcrt-induced EPSCs revealed a significant main effect of stress (F(1,56) = 7.809, P < 0.01), where the effect of CUS was dependent on the genotype (F(1,56) = 4.046, P < 0.05), but no main effect of genotype. There were no differences in basal responses between groups. Spine density analysis of two-photon laser images of the recorded cells revealed a decrease in spine density in WT CUS mice as compared to all other groups (P < 0.02) ( Fig. 3e) . Two-way ANOVA for spine density in the recorded cells revealed a significant main effect of stress (F(1,117) = 4.487, P < 0.05) and genotype (F(1,117) = 4.183, P < 0.05), but the effect of CUS did not depend on the genotype. The results demonstrate that REDD1-knockout mice display resilience to the effects of chronic stress on anhedonic behavior, mTORC1 signaling, and number and function of spine synapses in PFC.
We next tested whether REDD1 expression in the mPFC is responsible for the behavioral effects of CUS using a viral expression approach (Fig. 4a) . We found that rats given a bilateral mPFC infusion of a REDD1-expressing viral vector (AAV-REDD1) showed behaviors similar to those observed in rats exposed to CUS, including a significant decrease in sucrose preference (P < 0.05), increased immobility in the forced swim test (P < 0.05) and increased latency to feed in the novelty-suppressed feeding test (P < 0.01) (Fig. 4b) .
Further, AAV-REDD1-infused rats showed an anxiogenic phenotype, spending significantly less time in the center of the open field relative to control virus-injected rats (P < 0.05) ( Fig. 4c) and less time and decreased entries in the open arms in the elevated plus maze (P < 0.01 and P < 0.05, respectively) ( Fig. 4d) . There was no effect on velocity or distance traveled, indicating that locomotor activity was unaffected.
To verify the expression and function of AAV-REDD1, we performed immunofluorescence to detect both eYFP, expressed by virus-infected neurons, and p-S6, a downstream substrate of S6K (Fig. 4e) . We found that AAV-REDD1 injection significantly decreased levels of p-S6 colocalization with eYFP, as compared with that in control-injected rats (P < 0.05). We confirmed this in a separate cohort by immunoblot analysis of microdissected mPFC. AAV-REDD1 infusion significantly increased REDD1 levels (P < 0.01) and decreased levels of p-mTOR and p-S6K compared to npg control virus (P < 0.01), demonstrating that REDD1 overexpression causes functional inhibition of mTORC1 signaling in the mPFC (Fig. 4f) .
In a separate cohort of AAV-REDD1-injected animals, we used the Enhanced Spine Platform (ESP) (see Online Methods) to perform dendritic spine analysis by assessing the eYFP-positive layer V neurons colocalized with DiOlistic labeling, a method to allow for analysis of spines in virus-infected cells. We found that AAV-REDD1 treatment led to atrophy of primary apical dendrites of layer V neurons (P < 0.05), as measured by spine density (Fig. 4g) . Moreover, the spine density decrease in AAV-REDD1-injected animals was observed specifically in functionally mature spines (i.e., mushroom and stubby spines) (P < 0.05), but not in immature filopodia or long-thin spines (Fig. 4h) .
Taken together, our results demonstrate that REDD1 expression is increased in PFC following CUS and is necessary and sufficient for the synaptic deficits and depressive behaviors caused by CUS (Fig. 1c) .
The synaptic alterations caused by REDD1 inhibition of mTORC1 are also consistent with regulation of mTORC1 via other convergent pathways. For example, stress decreases the expression of brain-derived neurotrophic factor (BDNF) 22 , which increases mTORC1 signaling via activation of Akt and inhibition of the TSC1-TSC2 complex 23, 24 . Consistent with this, mice lacking BDNF show reduced dendrite arbor and spine number and occlusion of hippocampal neuronal atrophy caused by chronic stress 25, 26 . The BDNF Val66Met polymorphism, which blocks the processing and release of BDNF, is associated with decreased hippocampal volume in humans and atrophy of neurons in PFC of mice with a knock-in of the Met66-encoding allele [27] [28] [29] . We have also reported that expression of GATA1, a transcriptional repressor, is increased in CUS-exposed rats and in postmortem dlPFC of patients with MDD and is sufficient to decrease expression of synapse-related genes 4 . Together, these findings demonstrate that npg chronic stress decreases the expression of synapse-related genes and synaptic protein synthesis by regulation of both transcriptional and translational mechanisms. These findings also identify points for new therapeutic interventions to block or reverse the effects of chronic stress on mTORC1 signaling, synaptogenesis and depressive behaviors.
METHODs
Methods and any associated references are available in the online version of the paper.
Note: Any Supplementary Information and Source Data files are available in the online version of the paper.
ONLINE METHODs
Animals. Male Sprague-Dawley rats with initial weights of 175-250 g were pair-housed and maintained in standard conditions with a 12-h light-dark cycle. Male REDD1-knockout mice or their WT littermates (22-30 g) were single-housed in plastic cages and maintained on a 12-h light-dark cycle. Rats and mice were handled before use, and food and water were provided ad libitum throughout the experiments except when noted. Animal use and procedures were in accordance with the US National Institutes of Health guidelines and approved by the Yale University Animal Care and Use Committee.
Drugs. Dexamethasone (Sigma) was administered intraperitoneally (i.p.) at a concentration of 10 mg per kg body weight (mg kg −1 ). RU-486 (Sigma) was administered i.p. at a concentration of 30 mg kg −1 .
Chronic unpredictable stress procedures. All animals were age-and weightmatched before commencement of CUS procedures. Rats were subjected to a sequence of 11 stressors over the course of 21 d. These stressors were cold (4 °C for 1 h), cage rotation (1 h Sucrose preference test. Rats were habituated to 1% sucrose for 48 h, and the side of the bottle was counterbalanced across animals and days. On testing day, rats were water-deprived for 6 h and then presented with preweighed identical bottles of 1% sucrose and water. One hour later, the bottles were removed and weighed to determine consumption of each fluid.
Sucrose consumption test.
Mice were habituated to 1% sucrose for 48 h. After overnight fluid deprivation, sucrose intake was measured the following morning by a 1-h test. The amount of sucrose intake was normalized to the amount of water intake (calculated from a 1 h consumption test following overnight fluid deprivation) for each animal.
Forced swim test. Rats were subjected to one 15-min session of swimming in water. Sessions were scored offline by a blind observer. Mice were subjected to one 10-min session of swimming in water. Minutes two through six were scored offline by a blind observer. Immobility was defined as the least amount of movement possible to stay afloat.
Novelty-suppressed feeding test. Rats were food-deprived overnight and then placed in an open field in the dark with pellets of food in the center. Time elapsed until the first bite of food was recorded. Immediately after the novelty test, home cage feeding was tested to verify motivation for food.
Elevated plus maze. Activity in an elevated-plus-maze apparatus with two open and two closed arms was measured over a 5-min period. For mice, frequency and time spent in open and closed arms were measured using the AnyMaze tracking system, whereas for rats, this was measured by a blind observer.
Open field.
Activity in an open field was measured over a 10-min period with AnyMaze (mice) or Ethovision (rats). Time spent in margin and center, total distance and mean speed were measured during the session.
Western blotting. Rodents were rapidly decapitated, and synaptoneurosomeenriched fractions were prepared from PFC tissue samples and sonicated in lysis buffer. Protein was electrophoretically separated on a 7.5% SDS PAGE gel and transferred to a PVDF membrane. Blots were incubated in the appropriate primary antibody (specific for p-S6 kinase (Thr389; Cell Signaling 9234; 1:1,000); S6 kinase (Cell Signaling 2708; 1:1,000); p-mTOR XP (Ser2448; Cell Signaling 5536; 1:500); mTOR (Cell Signaling 2983; 1:1,000); p-4EBP1 (Thr37/Thr46); Cell Signaling 2855; 1:500); p-ERK (Thr202/Tyr204; Cell Signaling 4370; 1:1,000); ERK (Cell Signaling 4695; 1:1,000); p-Akt (Ser473; Cell Signaling 4058; 1:1,000); Akt (Cell Signaling 9272; 1:1,000); GAPDH (Advanced Immunochemical 2-RGM2; 1:20,000); REDD1 (Proteintech 10638-1-AP; 1:500); TSC2 (Santa Cruz sc-893; 1:1,000); and PSD-95 (Invitrogen 51-6900; 1:1,000)) and developed using enhanced chemiluminescence (GE Biosciences). Optical densities of the bands were analyzed using National Institutes of Health ImageJ software. For analysis, protein levels were normalized to total protein levels then expressed as a percentage of that in control animals. For figure panels, contrasts have been adjusted linearly for easier viewing of bands.
Quantitative real-time PCR. RNA was purified using RNAqueous (Ambion), and 500 ng of total RNA was used for cDNA synthesis (Genisphere). Genespecific primers for REDD1 were designed using Primer 3 software. PCR was run on the Eppendorf Realplex Mastercycler using SYBR Green (Qiagen). Ct values of genes of interest were normalized to that of housekeeping genes (HMBS or GAPDH).
ELISA.
Trunk blood was collected and then allowed to sit overnight at 4 °C. The following day, samples were centrifuged at 3,000g and then the supernatant was collected and stored at −80 °C until use. All samples were run in duplicate using the Corticosterone ELISA (Enzo), and concentration was determined as percentage bound using a standard curve ranging from 32 to 20,000 pg mL −1 .
Electrophysiological recordings and neurobiotin-labeled spine density analysis. Brain slices were prepared as previously described 14, 21 . Briefly, mice were anesthetized (chloral hydrate, 400 mg kg −1 , i.p.), and brains were removed. Coronal slices 400-µm thick were cut from a block of tissue containing the mPFC in ice-cold sucrose-ACSF with an oscillating-blade tissue slicer (Leica VT 1000S; GMI). Slices were placed in a submerged recording chamber; bath temperature was then raised slowly to 32 °C. The standard ACSF (pH 7.35), equilibrated with 95% O 2 5% CO 2 , contained 128 mM NaCl, 3 mM KCl, 2 mM CaCl 2 , 2 mM MgSO 4 , 24 mM NaHCO 3 , 1.25 mM NaH2PO 4 and 10 mM d-glucose. There was a recovery period of 1-2 h before recording. Pyramidal neurons in layer V were patched under visual control using a microscope (60× IR lens; Olympus, Center Valley Pennsylvania) with infrared differential interference contrast microscopy. Patch pipettes (3-5 MΩ) were pulled from glass tubing by using a Flaming-Brown Horizontal Puller (Sutter, Novato, California). The pipette solution contained the following: 115 mM potassium gluconate, 5 mM KCl, 2 mM MgCl 2 , 2 mM Mg-ATP, 2 mM Na 2-ATP, 10 mM Na 2 -phosphocreatine, 0.4 mM Na 2-GTP and 10 mM HEPES, pH 7.33. Neurobiotin (0.3%) was added to the pipette solution to mark cells for later processing and imaging.
Whole-cell recordings were made with an Axoclamp-2B amplifier (Molecular Devices, Sunnyvale, California). The output signal was low-pass-filtered at 3 kHz and digitized at 15 kHz; data were acquired by pClamp 9.2/Digidata 1320 software (Molecular Devices). Postsynaptic currents were studied in the continuous single-electrode voltage-clamp mode (3,000 Hz low-pass filter) clamped near resting potential (75 mV ± 5 mV).
After completion of recording, slices were transferred to 4% paraformaldehyde (0.1 M phosphate buffer) and then processed with streptavidin conjugated to Alexa Fluor 594 (1:1,000) for visualization of labeled cells. Labeled neurons within layer V of prelimbic mPFC were imaged with a two-photon Ti:sapphire laser-scanning system (810 nanometers; Mai Tai, Spectra Physics, Mountain View, California) coupled to direct detection Radiance 2000 BioRad laser scanner (Zeiss Microimaging, Thornwood, New York) mounted on a Olympus BX50WI microscope, using a 60× (0.9 numerical aperture) water-immersion objective. For spine density analysis, z stacks usually consisted of 2-5 scans at high zoom at 1-µm steps in the z axis. Spine density was sampled in apical tufts.
Ballistic dye labeling and microscopy and Afraxis ESP dendritic spine analysis. Ballistic delivery of DiI (48 h diffusion) to 300-µm thick sections was used to individually label neurons. Dendritic segments of 50 µm in length were scanned (0.1 × 0.1 0.33 µm) using laser-scanning confocal microscopy (Olympus npg
